KLF5 regulates the integrity and oncogenicity of intestinal stem cells

Takeo Nakaya1, Seishi Ogawa2, Ichiro Manabe2

  • 1Authors' Affiliations: Department of Molecular Pathology and Translational Research Unit, Tokyo Medical University; Cancer Genomics Project; Departments of Pathology, and Cardiovascular Medicine; Animal Resources, Graduate School of Medicine, University of Tokyo; Honeybee Science Research Center, Tamagawa University; Department of Gastroenterology, School of Medicine, Keio University, Tokyo; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto; Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, Kobe; Jichi Medical University, Shimotsuke, Tochigi, Japan; and Hubrecht Institute and KNAW, Utrecht, the NetherlandsAuthors' Affiliations: Department of Molecular Pathology and Translational Research Unit, Tokyo Medical University; Cancer Genomics Project; Departments of Pathology, and Cardiovascular Medicine; Animal Resources, Graduate School of Medicine, University of Tokyo; Honeybee Science Research Center, Tamagawa University; Department of Gastroenterology, School of Medicine, Keio University, Tokyo; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto; Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, Kobe; Jichi Medical University, Shimotsuke, Tochigi, Japan; and Hubrecht Institute and KNAW, Utrecht, the NetherlandsAuthors' Affiliations: Department of Molecular Pathology and Translational Research Unit, Tokyo Medical University; Cancer Genomics Project; Departments of Pathology, and Cardiovascular Medicine; Animal Resources, Graduate School of Medicine, University of Tokyo; Honeybee Science Research Center, Tamagawa University; Department of Gastroenterology, School of Medicine, Keio University, Tokyo; Department of Pharmacology, Graduate School of Medicine, Kyoto University, Kyoto; Laboratory for Animal Resources and Genetic Engineering, RIKEN Center for Developmental Biology, Kobe; Jichi Medical University, Shimotsuke,

Cancer Research
|March 15, 2014
PubMed

Related Concept Videos

Renewal of Intestinal Stem Cells01:23

Renewal of Intestinal Stem Cells

The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
1.8K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.3K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

2.0K
Adult Stem Cells01:33

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously...
27.8K